Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

52 publications found

  1. Gordon AJ, Hatch MA, Kropp FB, Liebschutz JM, Mooney LJ, Cochran G. Twenty-five years of the NIDA clinical trials network and the future of addiction research. Journal of Substance Use & Addiction Research 2026: 210140 (in press). [doi: 10.1016/j.josat.2026.210140] PMID: 42893770
  2. Paschen-Wolff MM, Tross S, Nelson CM, Hatch MA, Meche D, Ertl MM, Wright L, Laschober TC. Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the Southern United States. AIDS Care 2025;37(1):21-32. [doi: 10.1080/09540121.2024.2438923] PMID: 39651544
  3. Tross S, Laschober TC, Paschen-Wolff M, Ertl M, Nelson CM, Wright L, Lancaster C, Feaster DJ, Monger M, Toal P, Fegley JP, Meche D, Hankey C, Woodhouse C, Spector A, Dresser L, Moran L, Jelstrom E, Haynes L, Shoptaw S, Hatch MA. Willingness to use oral and long-acting injectable PrEP in substance-using men who have sex with men (SU-MSM) in high HIV incidence Southern U.S. cities: A NIDA Clinical Trials Network study. AIDS and Behavior 2025;29(4):1192-1204. [doi: 10.1007/s10461-024-04594-7]
  4. Le MH, Laschober TC, Tross S, Paschen-Wolff M, Ertl MM, Wright L, Hatch MA. Attitudes toward and experience with naloxone among people who use drugs in the Southeastern United States. International Journal of Drug Policy 2025;139:10479. [doi: 10.1016/j.drugpo.2025.104769] PMID: 40073718
  5. Ertl MM, Woodhouse C, Meche D, Forrest DW, Fegley J, Paschen-Wolff M, Laschober TC, Hatch MA, Nelson CM, Wright L, Tross S. Using structural modeling to examine barriers and facilitators of HIV pre-exposure prophylaxis willingness and length of use in men who have sex with men who use substances in eight Southern U.S. cities. AIDS Patient Care and STDS 2025;39(6):245-256. [doi: 10.1089/apc.2025.0036] PMID: 40401366 PMCID: PMC12172640
  6. Paschen-Wolff MM, Laschober TC, Spector AY, Ertl MM, Nelson CM, Hatch MA, Lancaster C, Wright L, Tross S. “PrEP is always on the table”: Mixed methods study of provider willingness to refer/link clients to PrEP in community sexual health and drug use-related programs. Journal of HIV/AIDS & Social Services 2025 (in press). [doi: 10.1080/15381501.2025.2545265]
  7. Simon CB, Hus C, Prado MG, West II, Kwun CGC, LeMaster JW, Hatch MA, Tong ST, Stephens KA. Examining removal of federal waiver restrictions to prescribing buprenorphine in primary care. Journal of the American Board of Family Medicine 2025;38(3):752-756. [doi: 10.3122/jabfm.2024.240453R1] PMID: 41115754
  8. Lancaster C, Laschober TC, Nelson CM, Hatch MA, Paschen-Wolff MM, Ertl MM, Wright L, Tross S. Predicting willingness to use MOUD: An application of the theory of reasoned action and theory of planned-behavior. Journal of Drug Issues 2025 (in press). [doi: 10.1177/00220426251395179]
  9. Orozco K, Laschober TC, Tross S, Ertl MM, Paschen-Wolff MM, Nelson CM, Lancaster C, Hatch MA. Future pandemic preparedness: conceptualizing vaccine willingness in drug-using populations during COVID-19 in Southeastern U.S. cities. Journal of HIV/AIDS & Social Services 2025 (in press). [doi: 10.1080/15381501.2025.2591675]
  10. Hatch MA, Ertl M, Closs D, Keeshin S, Feinberg J, Orozco K, Tross S. HIV prevention in syringe service programs since the start of COVID-19: Where do we go from here? Current HIV/AIDS Reports 2025;22(1):13. [doi: 10.1007/s11904-024-00721-0] PMID: 39812953 PMCID: PMC12640190
  11. Hatch MA, Laschober TC, Paschen-Wolff M, Ertl MM, Nelson CM, Wright L, Lancaster C, Feaster DJ, Forrest D, Hankey C, Monger M, Fegley JP, Irving R, Young C, Rose J, Spector A, Dresser L, Moran L, Jelstrom E, Tross S. PrEP for people who use opioids: A NIDA Clinical Trials Network survey study in Southern U.S. cities where HIV incidence is high. Drug and Alcohol Dependence 2024;257:111133. [doi: 10.1016/j.drugalcdep.2024.111133] PMID: 38447393 PMCID: PMC11131129
  12. Hatch MA, Laschober TC, Ertl MM, Paschen-Wolff MM, Norman G, Wright L, Tross S. Program director reports of COVID-19 lockdown-driven service changes in community-based STI clinics and syringe services programs in the southeastern U.S. AIDS Education and Prevention 2024;36(2):129-40. [doi: 10.1521/aeap.2024.36.2.129] PMID: 38648174 PMCID: PMC11608127
  13. Hatch MA, Wells EA, Masters T, Beadnell B, Harwick R, Wright L, Peavy M, Ricardo-Bulis E, Wiest K, Shriver C, Baer JS. A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients’ sexual risk behavior. Journal of Substance Abuse Treatment 2022;140:108826. [doi: 10.1016/j.jsat.2022.108826] PMID: 35751944
  14. Braciszewski JM, Idu AE, Yarborough BJH, Stumbo SP, Bobb JF, Bradley KA, Rossom RC, Murphy MT, Binswanger IA, Campbell CI, Glass JE, Matson TE, Lapham GT, Loree AM, Barbosa-Leiker C, Hatch MA, Tsui JI, Arnsten JH, Stotts A, Horigian V, Hutcheson R, Bart G, Saxon AJ, Thakral M, Grant DL, Pflugeisen CM, Usaga I, Madziwa LT, Silva A, Boudreau DM. Sex differences in comorbid mental and substance use disorders among primary care patients with opioid use disorder. Psychiatric Services 2022;73(12):1330-1337. [doi: 10.1176/appi.ps.202100665] PMID: 35707859 PMCID: PMC9722542
  15. Hatch-Maillette MA, Peavy KM, Tsui JI, Banta-Green CJ, Woolworth S, Grekin P. Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives. Journal of Substance Abuse Treatment 2021;124:108223. [doi: 10.1016/j.jsat.2020.108223] PMID: 33342667 PMCID: PMC8005420
  16. Hatch-Maillette MA, Donovan DM, Laschober TC. Dosage of booster phone calls following an SBIRT intervention in the emergency department for reducing substance use. Journal of Substance Abuse Treatment 2020;116:108043. [doi: 10.1016/j.jsat.2020.108043] PMID: 32741496 PMCID: PMC7399209
  17. Barbosa-Leiker C, Campbell ANC, Pavlicova M, Scodes J, Burlew AK, Hatch-Maillette MA, Mennenga SE, Mitchell SG, Novo P, Nunes EV, Rotrosen J, Greenfield SF. Substance use and mental health in emerging adult vs. older adult men and women with opioid use disorder. American Journal on Addictions 2020;29(6):536-542. [doi: 10.1111/ajad.13059] PMID: 32438502 PMCID: PMC7657988
  18. Hatch-Maillette MA, Harwick R, Baer JS, Masters T, Cloud K, Peavy M, Wiest K, Wright L, Beadnell B, Wells EA. Increasing substance use disorder counselors’ self-efficacy and skills in talking to patients about sex and HIV risk: A randomized training trial. Drug and Alcohol Dependence 2019;199:76-84. [doi: 10.1016/j.drugalcdep.2019.02.023] PMID: 30829142 PMCID: PMC6759413
  19. Hatch-Maillette MA, Harwick R, Baer JS, Masters T, Cloud K, Peavy M, Wiest K, Wright L, Beadnell B, Wells EA. Counselor turnover in substance use disorder treatment research: Observations from one multisite trial. Substance Abuse 2019;40(2):214-220. [doi: 10.1080/08897077.2019.1572051] PMID: 30829142
  20. Campbell ANC, Barbosa-Leiker C, Hatch-Maillette M, Mennenga SE, Pavlicova M, Scodes J, Saraiya T, Mitchell SG, Rotrosen J, Novo P, Nunes EV, Greenfield SF. Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial; Brief report. American Journal on Addictions 2018;27(6):465-470. [doi: 10.1111/ajad.12784] PMID: 30106494 PMCID: PMC6124662